| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,146 |
10,632 |
$418K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,762 |
5,201 |
$295K |
| 99384 |
|
810 |
701 |
$72K |
| 99335 |
|
1,335 |
1,027 |
$68K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,110 |
4,031 |
$67K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
770 |
515 |
$26K |
| 95117 |
|
1,408 |
488 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,499 |
464 |
$9K |
| 96160 |
|
1,111 |
920 |
$9K |
| 92551 |
|
1,246 |
1,034 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
952 |
707 |
$7K |
| 86580 |
|
1,003 |
847 |
$6K |
| 99173 |
|
878 |
731 |
$6K |
| 3078F |
|
9,672 |
6,915 |
$4K |
| 3074F |
|
8,961 |
6,473 |
$3K |
| 96127 |
|
837 |
700 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,160 |
1,586 |
$3K |
| 3079F |
|
1,791 |
1,359 |
$2K |
| 94060 |
|
67 |
63 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,101 |
2,990 |
$1K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
289 |
247 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
50 |
31 |
$1K |
| 81002 |
|
649 |
463 |
$899.98 |
| 94618 |
|
62 |
58 |
$787.38 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
105 |
86 |
$754.92 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,294 |
945 |
$637.36 |
| 94200 |
|
69 |
65 |
$604.29 |
| 80305 |
|
149 |
114 |
$529.12 |
| 3075F |
|
1,321 |
957 |
$472.14 |
| 94770 |
|
69 |
65 |
$442.15 |
| 94664 |
|
67 |
63 |
$422.70 |
| 3008F |
|
952 |
766 |
$320.00 |
| 94726 |
|
14 |
13 |
$257.93 |
| 3077F |
|
94 |
78 |
$84.68 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
64 |
50 |
$29.85 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15 |
14 |
$11.84 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20 |
13 |
$3.87 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
194 |
162 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
724 |
541 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
1,855 |
1,428 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
7,804 |
5,208 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
208 |
176 |
$0.00 |